Summary
Signal counts
Assets tracked: 1
Watchlist assets: 0
Registry stop assets: 0
Sponsor overview
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT06991738
Assets
Linked programs
- 68Ga-DOTA-TATE PET Scan: Low Signal (1/5)